Relation between age and coronary heart disease (CHD) risk in Asian Indian patients with diabetes: A cross-sectional and prospective cohort study

Diabetes Research and Clinical Practice

Volumn 81, Issue 2, 2008, Pages 243-249

  Idris, I ^a   Deepa, R ^b   Fernando, D J ^a   Mohan, V ^b  

^a SHERWOOD FOREST HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b MADRAS DIABETES RESEARCH FOUNDATION   (India)

Author keywords

Age; Asian Indians; CHD risk; CUPS; CURES; Diabetes; Statins

Indexed keywords

ADULT; AGE; ARTICLE; DIABETES MELLITUS; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; RISK; RISK ASSESSMENT;

ADULT; COHORT STUDIES; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIABETIC ANGIOPATHIES; HUMANS; INDIA; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; RURAL POPULATION; SMOKING; URBAN POPULATION;

EID: 47649120657     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.04.006     Document Type: Article

References (34)

1. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes, estimates for the year 2000 and projections for 2030. Diabet. Care 27 (2004) 1047-1053
2. Yusuf S., Reddy S., Ounpuu S., and Anand S. Global burden of cardiovascular diseases. Part II. Variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 104 (2001) 2264-2855
3. Assessment of Burden of Non-communicable Diseases, Final Report of Project WR/SE IND RPC 001 RB 02-SE/02/419575, Indian Council of Medical Research, New Delhi, 2004, pp. 8-28.
4. Mohan V., Deepa R., Shanthirani S., and Premalatha G. Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India-The Chennai Urban population Study (CUPS no. 5). J. Am. Coll. Cardiol. 38 (2001) 682-687
5. Ma S., Cutter J., Tan C.E., Chew S.K., and Tai E.S. Associations of diabetes mellitus and ethnicity with mortality in a multiethnic Asian population: data from the 1992 Singapore National Health Survey. Am. J. Epidemiol. 158 (2003) 543-552
6. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in non diabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339 (1998) 229-234
7. Manuel D.G., Lim J., Tanuseputro P., Anderson G.M., Alter D.A., Laupacis A., and Mustard C.A. Revisiting rose: strategies for reducing coronary heart disease. BMJ 332 (2006) 659-662
8. Law M.R., Wald M.J., and Rudnicka A.R. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 28 326 (2003) 1423-1430
9. S. Siyambalapitiya, U. Bulugahapitiya, J. Sithole, S. Song, D. Fernando, I. Idris, Combining Population Health and Baseline Risk strategy by determining an age cut-offs for initiating statins in patients with diabetes: a population-based study Diabetes Care, 2007 [Epub ahead of print].
10. National Institute for Clinical Excellence. Management of Type 2 Diabetes: Management of Blood Pressure and Blood Lipids. National Institute for Clinical Excellence, London, 2002.
11. Kannel W.B., and McGee D.L. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabet. Care 2 (1979) 120-126
12. Clinical Guidelines Task Force. International Diabetes Federation, Global Guideline for Type 2 Diabetes, 2005, p. 48.
13. Collins R., Armitage J., Parish S., Sleight P., and Peto R. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361 (2003) 2005-2016
14. Colhoun H.M., Betteridge D.J., Durrington P.N., Hitman G.A., Neil H.A., Livingstone S.J., et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364 (2004) 685-696
15. Stevens R.J., Kothari V., Adler A.I., Stratton I.M., and Holman R.R. The UKPDS risk engine, a model for the risk of coronary heart disease in type 2 diabetes (UKPDS 56). Clin. Sci. 101 (2001) 671-679
16. Shanthi R.C.S., Rema M., Deepa R., and Mohan V. The Chennai Urban Population Study (CUPS)-methodological details (CUPS Paper no. 1). Int. J. Diab. Dev. Countries 19 (1999) 149-157
17. Deepa M., Pradeepa R., Rema M., Mohan A., Deepa R., Shanthirani S., et al. The Chennai Urban Rural Epidemiology Study (CURES): study design and methodology (urban component-CURES report 1). J. Assoc. Phys. India 51 (2003) 863-870
18. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults, Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497.
19. Patrono C., Garcia Rodriguez L.A., Landolfi R., and Baigent C. Drug therapy: low-dose aspirin for the prevention of atherothrombosis. NEJM 353 (2005) 2373-2383
20. Enas E.A., Garg A., Davidson M.A., Nair V.M., Huet B.A., and Yusuf A. Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. Indian Heart J. 48 (1996) 343-353
21. Lee J., Heng D., Chia K.S., Chew S.K., Tan B.Y., and Hughes K. Risk factors and incident coronary heart disease in Chinese Malay and Asian Indian males: the Singapore Cardiovascular Cohort Study. Int. J. Epidemiol. 30 (2001) 983-988
22. Balarajan R. Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales. BMJ 302 (1991) 560-564
23. Wild S.H., Laws A., Fortmann S., and Byrne C. Mortality from coronary heart disease and stroke for six ethnic groups in California 1985-1990. Ann. Epidemiol. 5 (1995) 432-439
24. Anand S.S., Yusuf S., Vuksan V., Devanesen S., Teo K.K., Montague P.A., et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 356 (2000) 279-284
25. Bhalodkar N.C., Blum S., Rana T., Kitchappa R., Bhalodkar A.N., and Enas E.A. Comparison of high density and low density lipoprotein cholesterol subclasses and sizes in Asian Indian women with Caucasian women from the Framingham Offspring Study. Clin. Cardiol. 28 (2005) 247-251
26. Misra A. Insulin resistance syndrome: current perspective and its relevance in Indians. Indian Heart J. 50 (1998) 385-395
27. Palaniappan L.P., Kwan A.C., Abbasi F., Lamendola C., McLaughlin T.L., and Reaven G.M. Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women. Metabolism 56 (2007) 899-904
28. Alberti K.G., Zimmet P., and Shaw J. Metabolic syndrome-a new world-wide definition A Consensus Statement from the International Diabetes Federation. Diabet. Med. 23 (2006) 469-480
29. Sundstrom J., Riserus U., Byberg L., Zethelius B., Lithell H., and Lind L. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. BMJ 332 (2006) 878-882
30. Kahn R., Buse, Ferrannini E., and Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes 28 (2005) 2289-2304
31. Lee J.D., Morrissey J.R., Mikhailidis D.P., and Patel V. CARDS on the table: should everybody with type 2 diabetes take a statin?. Curr. Med. Res. Opin. 21 (2005) 357-562
32. Barnett A.H., Dixon A.N., Bellary S., Hanif M.W., O'hare J.P., Raymond N.T., et al. Type 2 diabetes and cardiovascular risk in the UK south Asian community. Diabetologia 49 (2006) 2234-2246
33. Stephens J.W., Ambler G., Vallance P., Betteridge D.J., Humphries S.E., and Hurel S.J. Cardiovascular risk and diabetes. Are the methods of risk prediction satisfactory?. Eur. J. Cardiovasc. Prev. Rehabil. 11 (2004) 521-5218
34. Coleman R.L., Stevens R.J., Retnakaran R., and Holman R.R. Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes. Diabet. Care 30 (2007) 1292-1293